Avai Bio (AVAI) Invested Capital (2018 - 2023)
Avai Bio's Invested Capital history spans 5 years, with the latest figure at -$1.4 million for Q4 2023.
- For Q4 2023, Invested Capital fell 170.53% year-over-year to -$1.4 million; the TTM value through Dec 2023 reached -$1.4 million, down 170.53%, while the annual FY2023 figure was -$534259.0, N/A changed from the prior year.
- Invested Capital for Q4 2023 was -$1.4 million at Avai Bio, down from -$892302.0 in the prior quarter.
- Across five years, Invested Capital topped out at $281145.0 in Q3 2020 and bottomed at -$1.4 million in Q4 2023.
- The 4-year median for Invested Capital is -$268851.0 (2020), against an average of -$353998.7.
- The largest annual shift saw Invested Capital tumbled 3015.61% in 2019 before it surged 285.9% in 2020.
- A 4-year view of Invested Capital shows it stood at $72854.0 in 2019, then plummeted by 518.62% to -$304983.0 in 2020, then plummeted by 69.79% to -$517822.0 in 2022, then tumbled by 170.53% to -$1.4 million in 2023.
- Per Business Quant, the three most recent readings for AVAI's Invested Capital are -$1.4 million (Q4 2023), -$892302.0 (Q3 2023), and -$894781.0 (Q2 2023).